"The service was easy to use and the support was excellent
"When it comes to GLP-1 medications, safety should always be the top priority
When surveyed after the meal, men in the GLP-1 group showed a significant increase in feelings of satiety and fullness at 1 hour and 4 hours post-meal
The same analysis did not find a significant reduction in overall blood clot or DVT risk, which is why your vein doctor's full picture of your health still matters when assessing your individual risk
FDA-approved GLP-1 medications used for weight loss include: Semaglutide (brand names: Ozempic, Wegovy) Tirzepatide (dual GIP/GLP-1 agonist) GLP-1s work primarily through the gut-brain axis, helping patients feel full sooner and reducing cravingsmaking it easier to eat less without feeling deprived
And in 2021, the results from a series of five STEP trials (Semaglutide Treatment Effect in People with obesity) demonstrated marked weight loss even in individuals without type 2 diabetes (T2DM): Phase 3, for example, showed an average loss of about 15 percent over 68 weeks, more than double achieved by any prior obesity drug